English, Article edition: Acamprosate: Pharmacoeconomic Implications of Therapy Rachel H. Foster; Karen J. McClellan

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/93714
Physical Description
  • article
Language
  • English

Edition details

Title
  • Acamprosate: Pharmacoeconomic Implications of Therapy
Author
  • Rachel H. Foster
  • Karen J. McClellan
Physical Description
  • article
Notes
  • _ Acamprosate is thought to reduce the craving for alcohol. The drug helps to maintain abstinence in alcohol-dependent patients who have successfully undergone detoxification. Abstinence rates during 3 to 12 months' treatment with acamprosate were approximately double those with placebo in most clinical trials, although abstinence rates were generally still <50% in patients assigned to receive acamprosate. _ The drug is generally well tolerated, with the most common adverse effect being diarrhoea. _ In a German cost-effectiveness model, a treatment programme including acamprosate was the dominant strategy, producing a lifetime cost saving of 2602 Deutschmarks (1992 to 1995 values) per additional abstinent patient compared with treatment without acamprosate. _ In a Belgian pharmacoeconomic model, total direct medical costs over 2 years were 21 301 Belgian francs (1997 values) per patient lower with a treatment programme including acamprosate than treatment without acamprosate in alcohol-dependent patients. _ The main factors in the cost savings with acamprosate in these models were reduced costs for acute hospitalisation and rehabilitation/​follow-up. _ The results of a cost-benefit analysis that considered both direct and indirect costs for the total alcohol-dependent population in Spain were consistently in favour of acamprosate. The lifetime net benefit for acamprosate over placebo (the incremental benefit) ranged between 61 642 million and 99 069 million pesetas (1996 values) in various scenarios with 40 to 60% of patients receiving treatment.
  • Pharmacoeconomics, Reviews-on-treatment, Acamprosate, Alcoholism, Cost-effectiveness, Cost-analysis, Cost-benefit
  • RePEc:wkh:phecon:v:16:y:1999:i:6:p:743-755
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment